Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4186713 | 0.80 | — | — | |
| SCHEMBL14012113 | 0.77 | — | — | |
| SCHEMBL9918180 | 0.72 | — | — | |
| SCHEMBL9619362 | 0.71 | EPHX1 (0.37) | EPHX1 | |
| SCHEMBL4993231 | 0.71 | — | — | |
| SCHEMBL23229700 | 0.70 | — | — | |
| SCHEMBL17701612 | 0.70 | — | — | |
| SCHEMBL15730451 | 0.70 | — | — | |
| SCHEMBL13094616 | 0.68 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL620516 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160152626-A1 | PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF | MERCK PATENT GMBH (DE) | 2016-06-02 | — | — | US | disclosed |
| US-7659413-B2 | (Meth) acryloyl group-containing oxetane compound and production method thereof | SHOWA DENKO K.K. (JP) | 2010-02-09 | — | — | US | disclosed |
| EP-1713787-B1 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO KK (JP) | 2009-12-30 | — | — | EP | disclosed |
| US-20070060760-A1 | (Meth) acryloyl group-containing oxetane compound and production method thereof | SHOWA DENKO K.K. (JP) | 2007-03-15 | — | — | US | disclosed |
| EP-1713787-A2 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2006-10-25 | — | — | EP | disclosed |
| WO-2005075445-A2 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO K.K. (JP) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160152626-A1 | PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF | FSHR, GNRHR, LHCGR | EPHX1 4810/4885 |
| US-20070060760-A1 | (Meth) acryloyl group-containing oxetane compound and production method thereof | OXGR1, ALKBH2, OXER1 | EPHX1 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.